Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000901036 | SCV001045383 | likely benign | not provided | 2018-02-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444998 | SCV002683162 | likely benign | Cardiovascular phenotype | 2021-01-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000901036 | SCV003918147 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | APOE: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV000901036 | SCV001809491 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000901036 | SCV001921397 | likely benign | not provided | no assertion criteria provided | clinical testing |